​

Senti Biosciences (SNTI) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Senti Biosciences Revenue Highlights

Latest Revenue (Y)

$22.00K

0

Main Segment (Y)

Reportable Segment

Senti Biosciences Revenue by Period

Senti Biosciences Revenue by Year

DateRevenueChange
2025-12-31$22.00K100.00%
2024-12-31--100.00%
2023-12-31$1.98M-39.81%
2022-12-31$3.29M43.43%
2021-12-31$2.29M481.47%
2020-12-31$394.00K363.53%
2019-12-31$85.00K-

Senti Biosciences generated $22.00K in revenue during NA 2025, up 100.00% compared to the previous quarter, and up 5.58% compared to the same period a year ago.

Senti Biosciences Revenue by Quarter

DateRevenueChange
2026-03-31--100.00%
2025-12-31$22.00K100.00%
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31-100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31--100.00%
2023-09-30$255.00K-72.79%
2023-06-30$937.00K-27.14%
2023-03-31$1.29M-773.30%
2022-12-31$-191.00K-112.60%
2022-09-30$1.52M36.82%
2022-06-30$1.11M0.36%
2022-03-31$1.10M39.22%
2021-12-31$793.00K-14.36%
2021-09-30$926.00K16.77%
2021-06-30$793.00K100.00%
2021-03-31--100.00%
2020-12-31$2.00K-

Senti Biosciences generated - in revenue during Q1 2026, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Senti Biosciences Revenue Breakdown

Senti Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 22
Reportable Segment$22.00K-
License-$800.00K

Senti Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 25: Reportable Segment (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 23Mar 23
License$200.00K$400.00K

Senti Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Jun 23: License (100.00%).

Senti Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
KPTIKaryopharm Therapeutics$146.07M$35.07M
IPSCCentury Therapeutics$109.16M-
XFORX4 Pharmaceuticals$35.11M$1.76M
CUECue Biopharma$27.47M$5.69M
COEPCoeptis Therapeutics$1.36M$62.87K
SNTISenti Biosciences$22.00K-
BRNSBarinthus Biotherapeutics--
MDCXMedicus Pharma--
ALGSAligos Therapeutics--
GNTAGenenta Science S.p.A.--

SNTI Revenue FAQ

What is Senti Biosciences’s yearly revenue?

Senti Biosciences's yearly revenue for 2025 was $22K, representing an increase of 100.00% compared to 2024. The company's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. SNTI's yearly revenue for 2023 was $1.98M, representing a decrease of -39.81% compared to 2022.

What is Senti Biosciences’s quarterly revenue?

Senti Biosciences's quarterly revenue for Q1 2026 was $0, a -100.00% decrease from the previous quarter (Q4 2025), and a 0% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $22K, a 100.00% increase from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024). SNTI's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024).

What is Senti Biosciences’s revenue growth rate?

Senti Biosciences's revenue growth rate for the last 3 years (2023-2025) was -98.89%, and for the last 5 years (2021-2025) was -99.04%.

What are Senti Biosciences’s revenue streams?

Senti Biosciences's revenue streams in c 25 are Reportable Segment

What is Senti Biosciences’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Senti Biosciences was Reportable Segment. This segment made a revenue of $22K, representing 100.00% of the company's total revenue.